Evidence map›Paper›PMID 25617623›Full record

ArticlePLoS genetics2015

Aberrant gene expression in humans.

Yong Zeng, Gang Wang, Ence Yang, Guoli Ji, Candice L Brinkmeyer-Langford, James J Cai

Abstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Toward transcriptomics as a primary tool for rare disease investigation.Cold Spring Harbor molecular case studies · 2022
    Article
  13. Article
  14. Where Are the Disease-Associated eQTLs?Trends in genetics : TIG · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. aTEMPO: Pathway-Specific Temporal Anomalies for Precision Therapeutics.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong ZengDepartment of Automation, Xiamen University, Xiamen, Fujian, China; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Gang WangDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Ence YangDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Guoli JiDepartment of Automation, Xiamen University, Xiamen, Fujian, China; Innovation Center for Cell Biology, Xiamen University, Xiamen, Fujian, China.
Candice L Brinkmeyer-LangfordDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
James J CaiDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America; Interdisciplinary Program in Genetics, Texas A&M University, College Station, Texas, United States of America.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Gene expression as an intermediate molecular phenotype has been a focus of research interest. In particular, studies of expression quantitative trait loci (eQTL) have offered promise for understanding gene regulation through the discovery of genetic variants that explain variation in gene expression levels. Existing eQTL methods are designed for assessing the effects of common variants, but not rare variants. Here, we address the problem by establishing a novel analytical framework for evaluating the effects of rare or private variants on gene expression. Our method starts from the identification of outlier individuals that show markedly different gene expression from the majority of a population, and then reveals the contributions of private SNPs to the aberrant gene expression in these outliers. Using population-scale mRNA sequencing data, we identify outlier individuals using a multivariate approach. We find that outlier individuals are more readily detected with respect to gene sets that include genes involved in cellular regulation and signal transduction, and less likely to be detected with respect to the gene sets with genes involved in metabolic pathways and other fundamental molecular functions. Analysis of polymorphic data suggests that private SNPs of outlier individuals are enriched in the enhancer and promoter regions of corresponding aberrantly-expressed genes, suggesting a specific regulatory role of private SNPs, while the commonly-occurring regulatory genetic variants (i.e., eQTL SNPs) show little evidence of involvement. Additional data suggest that non-genetic factors may also underlie aberrant gene expression. Taken together, our findings advance a novel viewpoint relevant to situations wherein common eQTLs fail to predict gene expression when heritable, rare inter-individual variation exists. The analytical framework we describe, taking into consideration the reality of differential phenotypic robustness, may be valuable for investigating complex traits and conditions.

Indexed as

Gene Expression RegulationGenetics, PopulationGenotypeChromosome MappingGene Expression ProfilingGenome-Wide Association StudyHumansPhenotypePolymorphism, Single NucleotidePromoter Regions, GeneticQuantitative Trait LociTwins

Identifiers

PMID25617623
PMCPMC4305293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.